It looks like you're new here. If you want to get involved, click one of these buttons!
https://www.nytimes.com/2018/04/06/health/trump-tariffs-china-devices-drugs.htmlSeveral companies, including Medtronic and Zimmer Biomet, have orthopedic device factories in China that export goods to the United States. ... Any products shipped from those operations to the United States would be subject to the tariffs. Medtronic declined to comment, saying it was still reviewing the proposal. ...
By Friday [April 6, after the initial announcement on tariffs], the major medical device company stocks had dipped along with the overall market. Medtronic shares were 2.7 percent lower for the week, and Zimmer Biomet was down 2.4 percent.
https://mutualfundobserver.com/discuss/discussion/42465/a-second-gentle-reminder#latestCome on David,,, Richard Cohen(WaPo) July 23. You were quoting him,,,,, right?
While I'm not as confident as Vanguard, their point is well taken - just because nominal returns are not expected to be as high as in the past doesn't mean that real returns won't be in the same ballpark.Vanguard believes it’s important for investors to consider real-return expectations when constructing portfolios, since today’s low stock dividend yields and U.S. Treasury bond yields are, in part, associated with lower expected inflation today than 20 or 30 years ago. [Vanguard projects a 50/50 portfolio to be in the 3.0%-4.5% real-return range]. Although this level is moderately below the actual average real return of 5.0% for the same portfolio since 1926, it potentially offers support for the continued feasibility of a 4% inflation-adjusted withdrawal program as a starting point.
© 2015 Mutual Fund Observer. All rights reserved.
© 2015 Mutual Fund Observer. All rights reserved. Powered by Vanilla